The global Drug Eluting Balloon Market is estimated to be valued at US$ 616.6 million in 2022 and is expected to exhibit a CAGR of 8.3% over the forecast period 2022-2030.

A) Market Overview:

Drug eluting balloons are medical devices used in the treatment of coronary artery disease and peripheral artery disease. These balloons are coated with anti-restenotic drugs, which are released during angioplasty to prevent the re-narrowing of the arteries. The use of drug ... Read more

The global Drug Eluting Balloon Market is estimated to be valued at US$ 616.6 million in 2022 and is expected to exhibit a CAGR of 8.3% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:
Drug eluting balloons are medical devices used in interventional cardiology procedures to deliver drugs directly to the targeted lesion. These balloons are particularly effective in preventing artery ... Read more

Drug eluting balloons are increasingly being used for percutaneous coronary interventions (PCI) as an alternative to bare metal and drug eluting stents. Drug eluting balloons are inflatable angioplasty balloons coated with an antiproliferative drug, which is slowly released at the treatment site during coronary angioplasty to prevent restenosis. They provide advantages such as reduced risk of late stent thrombosis and a lower rate of restenosis. They also avoid overstretching and damage to ... Read more

Drug eluting balloons (DEBs) are regular angioplasty balloons coated with an anti-proliferative medication intended to prevent restenosis (renarrowing) of the artery. They work by locally delivering drugs, which essentially slow down rapid regrowth of tissues in arteries. DEBs minimize the risk of restenosis which is a leading cause of repeat procedures in patients with coronary or peripheral artery disease.

The global Drug Eluting Balloon Market is estimated to be ... Read more